Skip to main content

Saturn Medic

Clinical Cases

Rapidly Progressive Glomerulonephritis (RPGN)

Clinical Subject Page

Also called

Crescentic glomerulonephritis

ICD-10

N01.9

Specialty

Nephrology

Onset

Acute

Reviewed

August 2026
On This Page

What is Rapidly Progressive Glomerulonephritis (RPGN)?

-Rapidly Progressive Glomerulonephritis (RPGN) is not a single disease but a syndrome caused by severe glomerular injury.

 

-The three major types are:

  • Type I: Anti-glomerular basement membrane (anti-GBM) disease
  • Type II: Immune complex-mediated disease
  • Type III: Pauci–immune disease, usually associated with antineutrophil cytoplasmic antibodies (ANCA)

 

-It typically presents with rapidly worsening kidney function, hematuria, proteinuria, and features of nephritic syndrome.

Etiology & Risk Factors

-Etiology

-Rapidly Progressive Glomerulonephritis (RPGN) is caused by severe glomerular injury due to:

  • Anti-GBM antibodies — Type I
  • Immune complex deposition — Type II
  • ANCA-associated small-vessel vasculitis — Type III

 

-Risk Factors:

  • Autoimmune disease
  • ANCA-associated vasculitis
  • Systemic lupus erythematosus
  • Recent or ongoing infection causing immune complex disease
  • Anti-GBM disease

Pathophysiology

Severe immune-mediated glomerular injury → disruption of the glomerular capillary wall → leakage of fibrin and inflammatory mediators into Bowman’s space → crescent formation → rapid destruction of glomeruli → rapid fall in GFR → acute kidney injury → kidney failure

Clinical Presentation

-Symptoms:

  • Reduced urine output
  • Dark or cola-colored urine
  • Hematuria
  • Fatigue
  • Nausea and vomiting
  • Dyspnea
  • Peripheral edema

 

-Signs:

  • Hypertension
  • Peripheral edema
  • Signs of fluid overload
  • Features of systemic vasculitis or autoimmune disease
Rapidly Progressive Glomerulonephritis (RPGN) Overview
Rapidly Progressive Glomerulonephritis (RPGN) Overview

History Taking

-Ask about:

  • Duration and rate of decline in urine output
  • Gross or microscopic hematuria
  • Frothy urine
  • Recent infection
  • Fever or weight loss
  • Skin rash or purpura
  • Joint pain
  • Sinus or nasal symptoms
  • Cough or hemoptysis
  • Dyspnea
  • Previous autoimmune disease
  • Previous kidney disease

Physical Examination

-General Examination

  • Blood pressure
  • Peripheral edema
  • Signs of fluid overload
  • Pallor when clinically relevant

 

-System-Specific Examination:

  • Skin for purpura or rash
  • Respiratory system for pulmonary hemorrhage or edema
  • ENT examination for features of granulomatosis with polyangiitis
  • Joints and other systems for systemic vasculitis

Investigations

-Complete Blood Count

Relevant for assessing:

  • Anemia

  • Infection

  • Eosinophilia when an alternative diagnosis is suspected

 

Biochemistry / Specific Tests

  • Serum creatinine and eGFR

  • Serum urea

  • Serum potassium

  • Serum bicarbonate

  • Urinalysis

  • Urine microscopy for dysmorphic red cells and red cell casts

  • Urine protein quantification

Cause-specific tests:

  • ANCA

  • Anti-GBM antibodies

  • Complement levels

  • Antinuclear antibodies and anti-double-stranded DNA when lupus is suspected

  • Infection-related testing when indicated

 

-Imaging

Renal ultrasound is useful to assess kidney size and exclude urinary obstruction.

-Chest imaging is indicated when pulmonary hemorrhage or pulmonary involvement is suspected.

 

-Special / Confirmatory Tests

Kidney biopsy is the definitive investigation when clinically feasible and should not be unnecessarily delayed.

Typical findings include:

  • Crescent formation involving glomeruli

  • Linear immunoglobulin deposition in anti-GBM disease

  • Granular immune deposits in immune complex disease

  • Minimal or absent immune deposits in pauci-immune disease

Diagnosis

Rapidly Progressive Glomerulonephritis (RPGN) should be suspected in a patient with:

  • Rapid decline in kidney function over days to weeks
  • Hematuria
  • Active urinary sediment, especially red cell casts
  • Variable proteinuria
  • Features of nephritic syndrome

Management

1. First-Line / Emergency Management

Rapidly Progressive Glomerulonephritis (RPGN) requires urgent nephrology management.

Immediate management may include:

  • High-dose glucocorticoids when severe immune-mediated disease is strongly suspected

  • Urgent treatment of hyperkalemia

  • Management of pulmonary edema and fluid overload

  • Correction of severe metabolic acidosis

  • Dialysis when indicated

 

2. Definitive Treatment

Treatment depends on the underlying cause:

  • ANCA-associated disease: glucocorticoids plus rituximab or cyclophosphamide

  • Anti-GBM disease: glucocorticoids plus cyclophosphamide and plasma exchange

  • Immune complex disease: treat the underlying disease, with immunosuppression when appropriate

 

3. Medical Treatment

  • High-dose glucocorticoids

  • Rituximab for appropriate ANCA-associated disease

  • Cyclophosphamide for severe immune-mediated disease

  • Cause-specific immunosuppressive therapy

  • Antihypertensive treatment

  • Diuretics for fluid overload when appropriate

 

4. Surgical / Procedural Treatment

No routine surgical treatment.

Important procedures may include:

  • Plasma exchange for anti-GBM disease and selected severe conditions

  • Dialysis for severe kidney failure or refractory complications

 

5. Supportive Management

  • Close monitoring of kidney function

  • Monitoring potassium and acid-base status

  • Fluid balance management

  • Avoid nephrotoxic medications

Complications

  • Acute kidney injury
  • Kidney failure
  • Severe hyperkalemia
  • Metabolic acidosis
  • Pulmonary edema
  • Pulmonary hemorrhage
  • Uremia
  • Chronic Kidney Disease (CKD)
  • End-Stage Renal Disease (ESRD)

Prognosis

-The prognosis of Rapidly Progressive Glomerulonephritis (RPGN)  depends on the underlying cause, severity at presentation, degree of crescent formation, baseline kidney function, and speed of treatment.

-Early diagnosis and urgent treatment can preserve kidney function, whereas delayed treatment may result in irreversible kidney failure.

Key Points / Clinical Pearls

  • Rapidly Progressive Glomerulonephritis (RPGN) is a severe syndrome causing rapid kidney function loss.
  • It is a nephrological emergency.
  • Crescent formation is a characteristic pathological finding.
  • The three major types are anti-GBM, immune complex-mediated, and pauci-immune.
  • Hematuria and red cell casts are important findings.
  • ANCA testing is important for suspected pauci-immune disease.
  • Anti-GBM antibody testing is essential when anti-GBM disease is suspected.
  • Kidney biopsy is a key diagnostic investigation.
  • Treatment depends on the underlying cause.
  • High-dose glucocorticoids are commonly used in severe immune-mediated disease.
  • Rituximab or cyclophosphamide may be required for ANCA-associated disease.
  • Anti-GBM disease usually requires plasma exchange with immunosuppressive therapy.
  • Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4S):S1-S276. KDIGO .
  • Kidney Disease: Improving Global Outcomes (KDIGO) Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. KDIGO .
  • Jennette JC, Nachman PH. ANCA Glomerulonephritis and Vasculitis. Clin J Am Soc Nephrol. 2017;12(4):601-611. Clinical Journal of the American Society of Nephrology .
  • Kallenberg CGM. Rapidly Progressive Glomerulonephritis. Clin Kidney J. 2009;2(4):223-229. Clinical Kidney Journal .
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Glomerular Diseases . National Institutes of Health.
  • National Library of Medicine (NIH). Rapidly Progressive Glomerulonephritis . StatPearls.
Test yourself

Practice Rapidly Progressive Glomerulonephritis (RPGN) questions

Lock in what you just read with exam-style MCQs and active-recall flashcards from Saturn Medic.

More in Nephrology System Clinical Cases

SaturnMedic